Silverstein Foundation
  • About
    • About Us
    • Scientific Advisory Board
    • Board of Trustees
  • Our Work
  • In the News
Select Page

Silverstein Foundation Announces Grant Funding to AcureX Therapeutics.

2021.08.31-Silverstein-Foundation-AcureX-Therapeutics-PRDownload

Prevail Therapeutics Acquired by Lilly

Prevail Announces First Patient Dosed

Aspen Neuroscience Announces $70 Million Series A Financing

Forbes: Meet Top Top VC In a Race To Find His Own Parkinson’s Cure

April, 2017—Two decades of successful investing in some of biotech’s biggest hits has made Jonathan Silverstein rich. Now he is looking for investments that could save his life.
« Older Entries

© 2022, The Silverstein Foundation for Parkinson's with GBA
Ansonia Station | P.O. Box 237137 | New York, NY 10023
[email protected]

  • Home
  • Contact Us
  • Privacy Policy
  • @SilversteinFNDN